


Novome Biotechnologies Email Formats
Biotechnology Research • South San Francisco, California, United States • 1-10 Employees
Key Contact at Novome Biotechnologies
Mehboob Ahmad
Director of Biotechnology
Company overview
| Headquarters | 279 E Grand Ave, South San Francisco, CA 94080, US |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Synthetic Biology, Therapeutics, Microbiome |
| Founded | 2016 |
| Employees | 1-10 |
| Socials |
About Novome Biotechnologies
Novome is building genetically engineered microbial medicines (GEMMs) that perform defined activities in the human gut to treat chronic diseases. We have developed the first platform for controlled colonization of the gut with engineered therapeutic bacteria, and are applying this to multiple disease areas as well as expanding our platform capabilities. Our lead program in enteric hyperoxaluria is currently in Phase 2 clinical trials, and we are focusing current research efforts on making a microbial cell therapy to treat inflammatory bowel disease (IBD).
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Novome Biotechnologies Tech Stack
Discover the technologies and tools that power Novome Biotechnologies's digital infrastructure, from frameworks to analytics platforms.
Digital asset management
Webmail
Reverse proxies
Miscellaneous
Frequently asked questions
4.8
40,000 users



